175 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal Phase III clinical trial data

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Pivotal Phase ◽

173 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase III clinical trial data

Rheumatology ◽

10.1093/rheumatology/key075.397 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Hasan Tahir ◽

Walter Maksymowych ◽

Ernest Choy ◽

Yusuf Yazici ◽

Jessica Walsh ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Pivotal Phase ◽

SAT0480 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data

10.1136/annrheumdis-2017-eular.5802 ◽

2017 ◽

Author(s):

V Strand ◽

I McInnes ◽

P Mease ◽

E Choy ◽

P Nash ◽

...

Keyword(s):

Clinical Trial ◽

Psoriatic Arthritis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data

Value in Health ◽

10.1016/j.jval.2017.08.2959 ◽

2017 ◽

Vol 20 (9) ◽

pp. A935 ◽

Cited By ~ 2

Author(s):

WP Maksymowych ◽

J Walsh ◽

H Thom ◽

C Kalyvas ◽

GF Rosal ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

AB0707 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data

10.1136/annrheumdis-2017-eular.5850 ◽

2017 ◽

Author(s):

W Maksymowych ◽

E Choy ◽

Y Yazici ◽

J Walsh ◽

H Thom ◽

...

Keyword(s):

Clinical Trial ◽

Ankylosing Spondylitis ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Trial Data ◽

Phase 3 ◽

Pivotal Phase ◽

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist, Prolongs Time to Seizure Recurrence in Patients with Epilepsy: Results of Pooled Phase III Clinical Trial Data (S56.005)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.s56.005 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. S56.005-S56.005 ◽

Author(s):

A. Laurenza ◽

J. French ◽

A. Gil-Nagel ◽

R. Guerrini ◽

D. Squillacote ◽

...

Keyword(s):

Clinical Trial ◽

Receptor Antagonist ◽

Ampa Receptor ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Seizure Recurrence ◽

Ampa Receptor Antagonist ◽

Patients With Epilepsy

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist, Prolongs Time to Seizure Recurrence in Patients with Epilepsy: Results of Pooled Phase III Clinical Trial Data (IN5-1.004)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.in5-1.004 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. IN5-1.004-IN5-1.004

Author(s):

A. Laurenza ◽

J. French ◽

A. Gil-Nagel ◽

R. Guerrini ◽

D. Squillacote ◽

...

Keyword(s):

Clinical Trial ◽

Receptor Antagonist ◽

Ampa Receptor ◽

Clinical Trial Data ◽

Trial Data ◽

Phase Iii ◽

Seizure Recurrence ◽

Ampa Receptor Antagonist ◽

Patients With Epilepsy

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79303-0 ◽

2009 ◽

Vol 2009 ◽

pp. 193-194

Author(s):

C.A. Lawton

Keyword(s):

Clinical Trial ◽

Proton Beam ◽

Clinical Trial Data ◽

Proton Beam Therapy ◽

Trial Data ◽

Phase Iii ◽

Positive Phase ◽

Phase Iii Clinical Trial

Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No

Radiotherapy and Oncology ◽

10.1016/j.radonc.2007.12.024 ◽

2008 ◽

Vol 86 (2) ◽

pp. 148-153 ◽

Cited By ~ 83

Author(s):

Herman Suit ◽

Hanne Kooy ◽

Alexei Trofimov ◽

Jonathan Farr ◽

John Munzenrider ◽

...

Keyword(s):

Clinical Trial ◽

Proton Beam ◽

Clinical Trial Data ◽

Proton Beam Therapy ◽

Trial Data ◽

Phase Iii ◽

Positive Phase ◽

Phase Iii Clinical Trial

The ustekinumab safety experience in patients with moderate to severe psoriasis: Results from pooled analyses of phase II and phase III clinical trial data

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2009.11.506 ◽

2010 ◽

Vol 62 (3) ◽

pp. AB132

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Clinical Trial Data ◽

Trial Data ◽

Severe Psoriasis ◽

Phase Iii ◽

Phase Iii Clinical Trial

Matching-Adjusted Indirect Comparison (MAIC) Of Crizotinib With Standard of Care In Progressed Nsclc ALK+ Patients Based On Real-World Evidence (RWE) And Clinical Trial Data In The Czech Republic

Value in Health ◽

10.1016/j.jval.2017.08.100 ◽

2017 ◽

Vol 20 (9) ◽

pp. A414

Author(s):

B Pasztor ◽

L Losenicky ◽

P Mazan ◽

J Duba ◽

M Kolek

Keyword(s):

Clinical Trial ◽

Czech Republic ◽

Real World ◽

Indirect Comparison ◽

Clinical Trial Data ◽

Standard Of Care ◽

Trial Data ◽

The Czech Republic ◽

Real World Evidence ◽